Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dyskinesia and eye tracking dysfunction in young schizophrenic patients - a pilot study.

R K Salokangas, E Syvälahti, I Lehtinen

    Methods and Findings in Experimental and Clinical Pharmacology
    |January 1, 1983
    PubMed
    Summary

    Young schizophrenic patients with dyskinetic symptoms and eye movement issues may indicate a distinct subgroup. Anticholinergic medication response can differentiate these patients from those with nuclear schizophrenia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Costs and benefits of plant allelochemicals in herbivore diet in a multi enemy world.

    Oecologia·2015
    Same author

    Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brain.

    Pharmacopsychiatry·2006
    Same author

    Measurement of anticholinergic effects of psychotropic drugs in humans.

    Pharmacopsychiatry·2005
    Same author

    Ethanol consumption and DRD2 gene TaqI a polymorphism among socially drinking males.

    American journal of medical genetics. Part A·2003
    Same author

    Structural magnetic resonance imaging in patients with first-episode schizophrenia, psychotic and severe non-psychotic depression and healthy controls. Results of the schizophrenia and affective psychoses (SAP) project.

    The British journal of psychiatry. Supplement·2002
    Same author

    [Has bipolar disorder been forgotten?].

    Duodecim; laaketieteellinen aikakauskirja·2002

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Clinical Pharmacology

    Background:

    • Schizophrenia is often associated with motor disturbances.
    • Anticholinergic medications are used to manage extrapyramidal side effects of antipsychotics.
    • The relationship between eye movement abnormalities and treatment response in schizophrenia requires further investigation.

    Purpose of the Study:

    • To investigate dyskinetic symptoms and eye movement disturbances in young schizophrenic patients.
    • To assess the effect of anticholinergic antiparkinsonian medication on these symptoms.
    • To explore potential differences between patient subgroups based on eye movement patterns.

    Main Methods:

    • Study included 15 young patients with schizophrenia.
    • Evaluated dyskinetic symptoms and eye movement disturbances (e.g., smooth pursuit).

    Related Experiment Videos

  • Administered anticholinergic medication (Biperiden) while maintaining stable neuroleptic dosage.

    • Main Results:

    • Dyskinetic symptoms appeared in young patients even with moderate, short-term high-dose neuroleptic exposure.
    • Patients with smooth pursuit movement disturbances showed less clinical disturbance but higher rates of depression.
    • Anticholinergic treatment worsened depression in patients with eye movement disturbances, unlike in others.

    Conclusions:

    • Disturbances in smooth pursuit movement may help identify a depressively colored marginal group within schizophrenia patients.
    • This subgroup may exhibit a different response to anticholinergic medication compared to the nuclear schizophrenia group.
    • Eye movement analysis could aid in differentiating schizophrenia patient subtypes and guiding treatment strategies.